Podcasts Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma mediated loss of bone strength May 07, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of the poster presentations to be held at the 2012 European Calcified Tissue Society Meeting. Comparison of Business Cases for Biosimilars and Biobetters Apr 23, 2012 Comparison of Business Cases for Biosimilars and Biobetters Alendronate prevents the negative effects of PPAR-y agonism on bone mass and bone strength at the proximal femur in the OVX rat Apr 16, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of her posters to be presented at the 2012 American Diabetes Association Meeting. Evaluation of MucilAir Apr 12, 2012 Evaluation of MucilAir Homozygous And Heterozygous P53 Knockout Rats Develop Metastasizing Sarcomas With High Frequency Apr 02, 2012 Homozygous And Heterozygous P53 Knockout Rats Develop Metastasizing Sarcomas With High Frequency Endotoxin & Its Relevance to Pharmaceutical Waters – Part 3 Mar 26, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 3 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 2 Mar 19, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 2 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 1 Mar 12, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 1 Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies Mar 06, 2012 Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies – SOT Poster 2012 Risk Assessment Identifying Bone as a Target Tissue in Preclinical Toxicology Studies Feb 28, 2012 Susan Smith, Senior Scientific Director and Bone Research Expert at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting. Displaying results 31-40 (of 47) |< < 1 - 2 - 3 - 4 - 5 > >|
Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma mediated loss of bone strength May 07, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of the poster presentations to be held at the 2012 European Calcified Tissue Society Meeting.
Comparison of Business Cases for Biosimilars and Biobetters Apr 23, 2012 Comparison of Business Cases for Biosimilars and Biobetters
Alendronate prevents the negative effects of PPAR-y agonism on bone mass and bone strength at the proximal femur in the OVX rat Apr 16, 2012 Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides an overview of one of her posters to be presented at the 2012 American Diabetes Association Meeting.
Homozygous And Heterozygous P53 Knockout Rats Develop Metastasizing Sarcomas With High Frequency Apr 02, 2012 Homozygous And Heterozygous P53 Knockout Rats Develop Metastasizing Sarcomas With High Frequency
Endotoxin & Its Relevance to Pharmaceutical Waters – Part 3 Mar 26, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 3
Endotoxin & Its Relevance to Pharmaceutical Waters – Part 2 Mar 19, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 2
Endotoxin & Its Relevance to Pharmaceutical Waters – Part 1 Mar 12, 2012 Endotoxin & Its Relevance to Pharmaceutical Waters – Part 1
Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies Mar 06, 2012 Assessment of Skeletal Muscle Mass and Nerve Conduction Velocity in Rat Preclinical Toxicology Studies – SOT Poster 2012
Risk Assessment Identifying Bone as a Target Tissue in Preclinical Toxicology Studies Feb 28, 2012 Susan Smith, Senior Scientific Director and Bone Research Expert at Charles River, provides an overview of her discussion to be held at the 2012 Society of Toxicology Meeting.
